TICKERNOMICS Sign up
Last Update: 2024-03-28 02:14:55
SciSparc Ltd. ( SPRC ) https://scisparc.com
1.86USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
Israel
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
-85.18%
SPRC
SPY
32.74%
SPRC
0.00%
SPY
92.93%
SPRC
0.00%
SPY
224.41%
SPRC
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
0.55
-1.53
0.18
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
0.31
0.21
0.08
-1232.38
0.00
0.00
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
0.00
0.00
0.00
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.27
376.18
378.08
0.00
Other Earnings and Cash Flow Stats:
SciSparc Ltd. ( SPRC ) Net Income TTM ($MM) is 0.00
SciSparc Ltd. ( SPRC ) Operating Income TTM ($MM) is 0.00
SciSparc Ltd. ( SPRC ) Owners' Earnings Annual ($MM) is -9.03
SciSparc Ltd. ( SPRC ) Current Price to Owners' Earnings ratio is -0.06
SciSparc Ltd. ( SPRC ) EBITDA TTM ($MM) is 0.00
SciSparc Ltd. ( SPRC ) EBITDA Margin is 0.00%
Capital Allocation:
SciSparc Ltd. ( SPRC ) has paid 0.00 dividends per share and bought back 4.292218 million shares in the past 12 months
SciSparc Ltd. ( SPRC ) has increased its debt by 0.0 million USD in the last 12 months
Capital Structure:
SciSparc Ltd. ( SPRC ) Interest-bearing Debt ($MM) as of last quarter is 0
SciSparc Ltd. ( SPRC ) Annual Working Capital Investments ($MM) are 1
SciSparc Ltd. ( SPRC ) Book Value ($MM) as of last quarter is 6
SciSparc Ltd. ( SPRC ) Debt/Capital as of last quarter is 0%
Other Balance Sheet Stats:
SciSparc Ltd. ( SPRC ) has 2 million in cash on hand as of last quarter
SciSparc Ltd. ( SPRC ) has 3 million of liabilities due within 12 months, and long term debt 0 as of last quarter
SciSparc Ltd. ( SPRC ) has 0 common shares outstanding as of last quarter
SciSparc Ltd. ( SPRC ) has 0 million USD of preferred stock value
Academic Scores:
SciSparc Ltd. ( SPRC ) Altman Z-Score is -9.23 as of last quarter
SciSparc Ltd. ( SPRC ) Piotroski Score is 2.00 as of last quarter
Corporate Governance:
SciSparc Ltd. ( SPRC ) largest shareholder is owning shares at 0.00 ($MM) value
(an insider) shares of SciSparc Ltd. ( SPRC ) for the amount of $ on
0.85% of SciSparc Ltd. ( SPRC ) is held by insiders, and 0.03% is held by institutions
SciSparc Ltd. ( SPRC ) went public on 2021-08-30
Other SciSparc Ltd. ( SPRC ) financial metrics:
FCF:-8.98
Unlevered Free Cash Flow:21.90
EPS:0.00
Operating Margin:0.00
Gross Profit Margin:0.00
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:0.00
Beta:0.00
Buffet's Owners Earnings:-9.03
Price to Owner's Earnings:-0.06
About SciSparc Ltd. ( SPRC ) :
SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum disorder and epilepsy. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in soft gel capsule form. It also has an agreement with the Sheba Fund for Health Services and Research to examine the potential role of SCI-210 for the treatment of status epilepticus; and The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation. SciSparc Ltd. has collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.